Mabpharm Limited (2181) Financial Statements

0 Followers

Mabpharm Limited Financial Overview

Mabpharm Limited's market cap is currently HK$1.92B. The company's EPS TTM is HK$0.014; its P/E ratio is 33.28; Mabpharm Limited is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 629.37M	¥ 258.23M	¥ 87.16M	¥ 55.92M	¥ 82.88M
Gross Profit	¥ 521.55M	¥ 219.39M	¥ 75.24M	¥ 40.54M	¥ 66.11M
Operating Income	¥ 4.68M	¥ -119.67M	¥ -201.98M	¥ -226.25M	¥ -297.52M
EBITDA	¥ 62.91M	¥ -67.81M	¥ -139.08M	¥ -152.08M	¥ -245.46M
Net Income	¥ 55.65M	¥ -127.95M	¥ -209.36M	¥ -210.62M	¥ -291.74M
Balance Sheet
Cash & Short-Term Investments	¥ 109.30M	¥ 89.34M	¥ 173.34M	¥ 48.61M	¥ 81.56M
Total Assets	¥ 1.15B	¥ 1.02B	¥ 1.03B	¥ 917.52M	¥ 899.90M
Total Debt	¥ 326.88M	¥ 293.09M	¥ 260.07M	¥ 126.34M	¥ 46.43M
Net Debt	¥ 217.57M	¥ 203.75M	¥ 86.73M	¥ 92.77M	¥ -35.13M
Total Liabilities	¥ 996.58M	¥ 927.28M	¥ 829.92M	¥ 516.58M	¥ 297.92M
Stockholders' Equity	¥ 157.37M	¥ 88.93M	¥ 205.06M	¥ 400.94M	¥ 601.98M
Cash Flow
Free Cash Flow	¥ -23.22M	¥ -63.58M	¥ 38.35M	¥ -182.01M	¥ -348.14M
Operating Cash Flow	¥ 80.78M	¥ -4.10M	¥ 57.39M	¥ -56.88M	¥ -199.47M
Investing Cash Flow	¥ -64.16M	¥ -98.20M	¥ -3.50M	¥ -104.95M	¥ -179.42M
Financing Cash Flow	¥ 3.29M	¥ 18.28M	¥ 85.60M	¥ 112.26M	¥ -17.78M

Currency in CNY

Mabpharm Limited Earnings and Revenue History

Income Statement >

Mabpharm Limited Debt to Assets

Balance Sheet >

Mabpharm Limited Cash Flow

Cash Flow >

Mabpharm Limited Forecast EPS vs Actual EPS

Earnings >